Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pediatrix Medical GroupFRA:PDC -1.77%55 Debt-to-Equity is 0.72 as of Mar. 2026, which is 12% below its 10-year median of 0.82. GuruFocus rates FRA:PDC with a GF Score™ of 55/100 and a GF Value™ of €11.54. The stock has 8 warning signs investors should review. Among 557 Healthcare Providers & Services companies, Pediatrix Medical Group ranks worse than 64.63% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Pediatrix Medical Group's Debt-to-Equity or its related term are showing as below:
FRA:PDC'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.56 Med: 0.82 Max: 2.41
Current: 0.72
During the past 13 years, the highest Debt-to-Equity Ratio of Pediatrix Medical Group was 2.41. The lowest was 0.56. And the median was 0.82.
FRA:PDC's Debt-to-Equity is ranked worse than 64.63% of 557
companies
in the Healthcare Providers & Services industry
Industry Median: 0.4
vs FRA:PDC: 0.72
Pediatrix Medical Group (FRA:PDC) Debt-to-Equity Explanation
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Pediatrix Medical Group Debt-to-Equity Related Terms
Pediatrix Medical Group Debt-to-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:PDC vs SEM, AGL, SGRY: Debt-to-Equity Comparison
For the Medical Care Facilities subindustry, Pediatrix Medical Group's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pediatrix Medical Group Debt-to-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pediatrix Medical Group's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Pediatrix Medical Group's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pediatrix Medical Group (FRA:PDC) has a Debt-to-Equity of 0.72 as of Mar. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Pediatrix Medical Group and its competitors. This is 12% below median its historical median of 0.82. Over the past decade, Pediatrix Medical Group's Debt-to-Equity has ranged from 0.56 to 2.41. According to the industry distribution chart, Pediatrix Medical Group ranks #360 out of 557 companies in the Healthcare Providers & Services industry, placing it in the top 64.6%.
Is Pediatrix Medical Group's Debt-to-Equity too high?
Pediatrix Medical Group's current Debt-to-Equity of 0.72 is 12% below median its 10-year median of 0.82. Over the past 10 years, this metric has ranged from a low of 0.56 to a high of 2.41. The Healthcare Providers & Services industry median Debt-to-Equity is 0.40. Pediatrix Medical Group's value of 0.72 is 80% above this industry median. Based on the distribution chart, Pediatrix Medical Group ranks #360 out of 557 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Pediatrix Medical Group has a GF Score™ of 55/100, reflecting its overall financial health beyond just this single metric.
How does Pediatrix Medical Group's Debt-to-Equity compare to SEM and AGL?
According to the Healthcare Providers & Services industry distribution chart, Pediatrix Medical Group ranks #360 out of 557 companies for Debt-to-Equity. This places Pediatrix Medical Group in the lower half of its industry. The industry median Debt-to-Equity is 0.40. Pediatrix Medical Group's value of 0.72 is 80% above this benchmark. Historically, Pediatrix Medical Group's own Debt-to-Equity has ranged from 0.56 to 2.41 over the past decade. While the company's 10-year median is 0.82 vs. the industry median of 0.40, Pediatrix Medical Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Healthcare Providers & Services company?
The median Debt-to-Equity among Healthcare Providers & Services companies is 0.40, based on 557 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pediatrix Medical Group's current Debt-to-Equity of 0.72 is 80% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Pediatrix Medical Group and its competitors. For the Healthcare Providers & Services industry, the median Debt-to-Equity is 0.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pediatrix Medical Group's current Debt-to-Equity is 0.72, which is 12% below median its own 10-year median of 0.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pediatrix Medical Group stock overvalued right now?
Pediatrix Medical Group (FRA:PDC) has a current Debt-to-Equity of 0.72. The stock's GF Value™ is €11.54, compared to a current price of €22.20 — trading 92.4% above its estimated fair value. The current Debt-to-Equity is 0.72, which is 12% below median its 10-year median of 0.82 and 80% above the Healthcare Providers & Services industry median of 0.40. Pediatrix Medical Group's overall GF Score™ is 55/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Pediatrix Medical Group (FRA:PDC), the current Debt-to-Equity is 0.72 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pediatrix Medical Group (FRA:PDC) Overvalued in 2026?
Based on GuruFocus' analysis, Pediatrix Medical Group stock appears to be overvalued.
The current stock price of €22.20 is trading 92.4% above its estimated GF Value™ of €11.54.
Key valuation signals for FRA:PDC:
Debt-to-Equity: 0.72 (12% below median its 10-year median of 0.82)
GF Value™: €11.54 vs. price of €22.20 (92.4% above fair value)
Industry Position: 80% above the Healthcare Providers & Services median (#360 of 557)
No single metric tells the full story. See the FRA:PDC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.
55GF Score
Get the complete analysis for FRA:PDC
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:PDC has been successfully added to your 
